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Nowadays, mass spectrometry-based proteomics is carried out
primarily in a bottom-up fashion, with peptides obtained after
proteolytic digest of a whole proteome lysate as the primary
analytes instead of the proteins themselves. This experimental
setup crucially relies on a protease to digest an abundant and
complex protein mixture into a far more complex peptide
mixture. Full knowledge of the working mechanism and
specificity of the used proteases is therefore crucial, both for the
digestion step itself as well as for the downstream identification
and quantification of the (fragmentation) mass spectra acquired
for the peptides in the mixture. Targeted protein analysis through
selected reaction monitoring, a relative newcomer in the specific
field of mass spectrometry-based proteomics, even requires a
priori understanding of protease behavior for the proteins of
interest. Because of the rapidly increasing popularity of proteo-
mics as an analytical tool in the life sciences, there is now a
renewed demand for detailed knowledge on trypsin, the work-
horse protease in proteomics. This review addresses this need
and provides an overview on the structure and working
mechanism of trypsin, followed by a critical analysis of its
cleavage behavior, typically simply accepted to occur exclusive-
ly yet consistently after Arg and Lys, unless they are followed by
a Pro. In this context, shortcomings in our ability to understand
and predict the behavior of trypsin will be highlighted, along
with the downstream implications. Furthermore, an analysis is
carried out on the inherent shortcomings of trypsin with regard
to whole proteome analysis, and alternative approaches will be
presented that can alleviate these issues. Finally, some reflec-
tions on the future of trypsin as the workhorse protease in mass
spectrometry-based proteomics will be provided.# 2013 Wiley
Periodicals, Inc. Mass Spec Rev 32:453–465, 2013
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I. INTRODUCTION
Trypsin is currently the most-frequently used protease in mass
spectrometry-based proteomics experiments. It owes this posi-
tion to its rather stringent cleavage specificity: it cleaves
carboxy-terminal (C-terminal) of Arg and Lys. In human
proteins, this cleavage pattern results in an average of 61
peptides per protein as calculated by DBToolkit (Martens,
Vandekerckhove, & Gevaert, 2005). The peptides are composed
of 1–2,374 residues, with an average of 9 and a standard
deviation of 15, a length that is suitable for analysis by the mass
spectrometer. When one miscleavage is allowed, these numbers
change to 120 peptides per protein. In this situation, the peptides
are composed of 1–2,433 residues, but with an average of 14 and
a standard deviation of 20. Furthermore, the presence of a C-
terminal basic residue enhances (positive) ionization, again
beneficial to mass spectrometrical analysis. A final, related
benefit is provided by the balance in basicity between the free
amine of the amino-terminus (N-terminus) of the peptide, and
the C-terminal Arg or Lys. This balance typically leads to good
fragmentation, as understood through the mobile-proton hypoth-
esis (Tabb et al., 2004). Yet, it has been repeatedly observed
empirically that cleavage does not occur after all Arg or Lys
residues. Several studies have therefore evaluated the cleavage
specificity of trypsin, to result in a set of rules of which the best
known is the failure to cleave at an Arg or Lys followed by a Pro.
Some of these rules are implemented in commonly used
peptide-to-spectrum matching algorithms to generate an accu-
rate set of theoretical peptides. These theoretical peptides are
fragmented in silico by the algorithm to yield theoretical
fragmentation spectra. Identification is achieved through match-
ing theoretical and experimental fragmentation spectra (Vaudel,
Sickmann, & Martens, 2012). An accurate understanding of
trypsin cleavage has even more value in situations where the
quantification of peptides is attempted. Indeed, if a particular
peptide can be split between a correctly cleaved variant that falls
within the analytical range of a mass spectrometer, and a
miscleaved variant that is too long to analyze, then the
quantification of that peptide will rely exclusively on the
observations of the correctly cleaved peptide, and underestimate
the actual occurrence of the precursor protein as a result. In the
case of targeted proteomics approaches, where specific peptides
are a priori selected as representative of a given protein of
interest, it would also be highly beneficial if the cleavage of
these peptides could be assessed before the choice is made. A
thorough understanding of trypsin, along with an appreciation of
the remaining gaps in our knowledge of this key protease, is
crucial to any researcher interested in the use of proteomics
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as an analytical tool. In the following sections, an overview of
the working mechanism and specificity of trypsin is therefore
presented, along with a brief history of the evolution of this
enzyme into a heavily engineered workhorse. Furthermore, the
accumulated knowledge on the finer details of its cleavage
preferences will be described, with critical notes on the contra-
dictions that can be found in these findings. An analysis is also
presented of the shortcomings of trypsin for specific tasks, along
with alternatives that can overcome these limitations. Finally, an
outlook on the future of trypsin in the field of mass spectrome-
try-based proteomics and beyond will be given.
II. THE OCCURRENCE OF TRYPSIN IN NATURE
Trypsin is one of the most-important digestive proteases in
most vertebrates. It is produced in the acinar cells of the
pancreas and is released via the pancreatic duct into the
gastrointestinal tract. After activation by enterokinase or
autocatalysis, it cleaves—together with chymotrypsin and
elastase—dietary proteins into peptides. The resultant peptides
are further digested by a variety of exopeptidases and the small
peptic fragments are subsequently absorbed by the intestine
(Whitcomb & Lowe, 2007).
In 1876, Keuhne discovered trypsin in the pancreatic fluid
of the bovine intestine during his studies on the intermediate
digestion of proteins in the gastrointestinal tract. Shortly after,
he found that trypsin was initially inactive but was subsequently
converted to its active form (Keuhne, 1877). This latter
observation formed the basis of the concept that zymogen
activation proceeds by proteolytic processing. Almost a century
after this discovery, in 1964, trypsin was one of the first proteins
that had its full amino acid sequence determined. At the same
time, the sequence of chymotrypsin became available and
comparison of both sequences demonstrated their extensive
similarity (Walsh & Neurath, 1964). Only later did it become
clear that both protein sequences contained the same experimen-
tal error; in trypsin, Asp 177, which is located in the primary
substrate-binding pocket, was identified as Asn, whereas in
chymotrypsin, Asp 102, which is part of the charge-relay
system, was also reported as Asn. This erroneous identification
was a common sequencing error at the time because there was
no good method available yet to discriminate between a free
acid and its amide (Neurath, 1994).
Although the main function of trypsin is the degradation
of digestive proteins, it can also activate the insulin receptor
by limited cleavage of its extracellular domain to result in
an insulin-like response in the absence of insulin (Clark
et al., 1991). Apart from its direct role as a protease, trypsin can
also serve as an indirect signaling molecule that regulates the
cell by cleaving and hence triggering proteinase-activated
receptors (PARs). PARs are a family of G protein-coupled
receptors, which are activated by different proteases: PAR-1 and
PAR-3 are activated by thrombin (Vu et al., 1991), whereas
PAR-2 is activated by trypsin or mast cell tryptase (Nystedt
et al., 1994). The protease cleaves the extracellular N-terminus
of the PAR. The released peptide subsequently activates the
cleaved receptor by binding to it. PAR-2, which is activated by
trypsin via cleavage of the trypsin cleavage site SKGR SLIGR,
is located at the apical membrane of enterocytes (De´ry
et al., 1998). Apart from its involvement in inflammation, little
is currently known about the physiological and pathophysiologi-
cal role of PAR-2 (Steinhoff et al., 2000).
A. Trypsin Amongst the Serine Proteases
Trypsin belongs to the group of serine proteases that emerged as
one of the most-abundant and functionally diverse group of
proteins during evolution. Serine proteases are found in all
kingdoms of life and have been identified in viral genomes
(Page & Di Cera, 2008). Serine proteases owe their name to the
nucleophilic Ser, which is part of the active site. They are
grouped into thirteen clans based on their catalytic mechanism,
and are subsequently divided into 40 families on the basis of
common ancestry (Rawlings & Barrett, 1994; Hedstrom, 2002).
A clan is identified by two letters: the first represents the
catalytic residue, which all of the families included in the clan
have in common. For trypsin, this first letter is P and not S as one
would intuitively think because the clan to which trypsin
belongs contains families with different catalytic residues. The
families are grouped by catalytic type, which is represented by
another two-letter denomination: the first letter is S (Ser) for
trypsin. This grouping with the respective group members can
be found in the MEROPS database (Rawlings, Barrett, &
Bateman, 2012).
Trypsin belongs to the clan PA proteases and is the
representative member. Members of this clan, such as chymo-
trypsin, have the trypsin fold and participate in many processes
such as digestion, coagulation, and immunity. Within this clan,
which contains twelve families, trypsin is found in the S1
family; the S refers to the catalytic Ser. This family is further
composed of two subfamilies: S1A and S1B. The S1B proteases
are all intracellular enzymes, whereas S1A proteases are
extracellular enzymes. Trypsin, which is secreted into the
gastrointestinal tract, is a member of the S1A subfamily (Di
Cera, 2009).
B. The Structure of Trypsin
The trypsin fold is characterized by a two beta-barrel structure;
by two six-stranded beta-barrels where the beta-strand topology
obeys the classic Greek-key architecture. The catalytic residues
are located at the interface between these barrels. His 57 and
Asp 102 originate from the N-terminal beta-barrel, whereas Ser
195 originates from the C-terminal barrel. Figure 1 gives a
cartoon representation of the trypsin fold. The structure is
stabilized by six completely conserved disulfide bridges to
withstand the extracellular reducing environment of the gastro-
intestinal tract (Halfon & Craik, 1998). Trypsin shares this fold
with other pancreatic proteinases such as chymotrypsin (Bode,
Fehlhammer, & Huber, 1976).
Trypsin and its zymogen trypsinogen were both amongst
the first proteins that had their structure determined (Bode
& Schwager, 1975; Bode, Fehlhammer, & Huber, 1976;
Fehlhammer, Bode, & Huber, 1977). This knowledge of
structure allowed an early comparison between both enzymes.
The transition from trypsinogen to trypsin, catalyzed by
either enterokinase (Kunitz, 1939) or trypsin itself (Kay &
Kassell, 1971), involves some chain rearrangements that do not
influence the overall fold. During this activation step, the bond
between Lys 15 and Ile 16 is cleaved. The new N-terminus,
which was originally unstructured and floating in the solvent,
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subsequently forms a salt bridge with Asp 194, which is located
next to the catalytic Ser (Oppenheimer, Labouesse, &
Hess, 1966). At the same time, the residues that surround the
active site change from their flexible state in trypsinogen, to an
ordered state in trypsin (Fehlhammer, Bode, & Huber, 1977).
This disorder-to-order transition results in a competent active
site and hence active trypsin.
Trypsin, chymotrypsin, and elastase bear the same fold but
have different specificity: the S1 pocket of trypsin is specific for
Arg and Lys, whereas the S1 pocket of chymotrypsin is specific
for the large aromatic residues Phe, Tyr, and Trp. This difference
originates from the residues that line the bottom of this pocket:
trypsin has an Asp at the bottom to allow the formation of a salt
bridge with Arg or Lys; chymotrypsin has a Ser at the bottom of
its S1 pocket that changes the specificity towards aromatic
residues. Elastase is specific for small aliphatic residues in its S1
pocket due to the presence of Val 216 and Thr 226, which line
the wall of the S1 pocket to prevent large residues from entering.
In trypsin and chymotrypsin, both these residues are Gly, as
illustrated in Figure 2 (Shotton &Watson, 1970).
C. The Reaction Mechanism of Trypsin
The reaction mechanism of serine proteases catalyzes the
hydrolysis of a peptide bond in two steps as illustrated in
Figure 3. In the first step, the nucleophilic Ser can attack the
substrate scissile bond by donating a proton to the catalytic His,
where the corresponding nitrogen has increased electronegativi-
ty due to the hydrogen bridge formed by the catalytic Asp. This
attack results in formation of a covalent acyl-enzyme intermedi-
ate and release of the N-terminal fragment of the cleaved peptide
bond. In the second step, a water molecule is activated by the
His and attacks the acyl-enzyme intermediate. This attack is
followed by release of the C-terminal fragment of the peptide
bond. This latter release is achieved by the return of the proton
from the histidine to the catalytic serine to reset the enzyme for
another cycle (Hedstrom, 2002; Voet & Voet, 2004).
This mechanism of catalysis is often referred to as the
charge-relay system (Blow, Birktoft, & Hartley, 1969), and has
three residues at its base, which form the catalytic triad: Ser 195,
His 57, and Asp 102. This conventional numbering scheme
follows the residue numbering of chymotrypsin. Within this
catalytic triad, the Ser functions as a nucleophile to initiate the
reaction, whereas the His has a dual function. In the first step
(acylation step), the catalytic His first acts as a general base to
accept a hydrogen atom from the hydroxyl group of the catalytic
Ser, which promotes the formation of the tetrahedral intermedi-
ate, and then the catalytic His acts as an acid by donating
the acquired proton group to the amine that leaves when the
tetrahedral intermediate collapses. Similar to the first step, in the
second step (deacylation step), the catalytic His acts as a base to
FIGURE 1. Cartoon representation of trypsin. This cartoon nicely illus-
trates the two beta-barrel structure of trypsin. The three residues of the
charge-relay system are shown in green. The black dashes represent the
connections between the catalytic residues. The conserved disulfide bridges
are shown in yellow. PDB-entry 2PTN of bovine trypsin was used to create
this figure (Walter et al., 1982).
FIGURE 2. Schematic representation of the specificity of the S1 pocket of trypsin, chymotrypsin and elastase.
The residues lining the S1 pocket determine the specificity of the different S1A proteases. Trypsin has an Asp at
the bottom of this pocket that forms a salt bridge with Arg or Lys while chymotrypsin has a Ser at this position
accounting for the preference of aromatic residues. Elastase on the other hand, has a Thr and Val lining the wall of
the S1 pocket, hence, only small aliphatic residues are able to bind the S1 pocket.
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activate the water molecule, and then acts as an acid and donates
the proton to the Ser hydroxyl oxygen that leaves. The Asp
is necessary to correctly orient the His to form a hydrogen
bond with it. This orientation facilitates the abstraction of the
proton from Ser and generates a potent nucleophile (Sprang
et al., 1987). This charge-relay system exists in all other related
serine proteases such as chymotrypsin (Freer et al., 1970) and
elastase (Shotton & Watson, 1970), but also in bacterial
proteinases such as subtilisin (Kraut, 1971). Other serine
proteases have a variation on the classic catalytic triad where the
Ser/His/Asp is replaced by Ser/His/Glu, Ser/His/His, or Ser/Glu/
Asp (Ekici, Paetzel, & Dalbey, 2008). Still other serine proteases
use a simpler catalytic mechanism composed of a dyad system
where a Lys or His assists the catalytic Ser (Paetzel &
Strynadka, 1999). Even though trypsin is arguably the most-
studied enzyme, its catalytic mechanism is a generally accepted
mechanism, which is still actively debated (Hedstrom, 2002;
Polga´r, 2005).
Experiments in which wild type trypsin hydrolysis of beta-
casein is carried out at a pH of 7.0, show that the apparent rate
constant for the hydrolysis of Arg-X (3.9  104 c1) is larger
than the apparent rate constant for the hydrolysis of Lys-X
(0.5  104 c1). This difference in apparent rate constant
indicates that trypsin has a certain preference for Arg (Vorob’ev
et al., 2000). Analysis of the pKa value at the different steps of
the catalytic mechanism revealed a pKa value of 6.5, which
corresponds to the deprotonation of the His. A pKa value of 9.8
(Arg-X) and 10.5 (Lys-X) corresponds to the ionization process
that can be attributed to the protonation of the amino group of Ile
26 which interacts with Asp 194. This stabilizes the active
conformation of trypsin (Vorob’ev et al., 2000).
The nomenclature of the substrate-binding subsites (also
referred to as specificity pockets, proposed by Schechter &
Berger, 1967) is commonly used as the convention nomencla-
ture. In most proteolytic enzymes, the active site is surrounded
by several subsites that each accommodates one amino acid
residue of the peptide substrate. The subsites occupied with the
residues located N-terminally to the cleavage site on the
substrate are referred to as S1, S2, etc. Likewise, the subsites on
the C-terminal end of the cleavage side are referred to as S1’,
S2’, etc. The cleaved peptide bond is the one between the
residues in subsites S1 and S1’. The positions of the residues in
the substrate peptide are referred to as P2, P1, P1’, P2’, etc. in
analogy to the subsites they occupy. The numbering in a given
peptide thus depends on the bond that is split (Schechter &
Berger, 1967). Figure 4 provides a schematic illustration of this
numbering convention.
III. THE USE OF TRYPSIN IN PROTEOMICS
Proteases are used extensively in protein chemistry, proteomics,
and biopharmaceutical manufacture. Amongst their tasks are
protein identification by peptide mass fingerprinting, protein
FIGURE 3. The reaction mechanism of trypsin. The arrows illustrate the flow of electrons at each of the different
steps in the reaction mechanism of trypsin. In the first step, an acyl-enzyme intermediate is formed and the
N-terminal part of the cleaved peptide bond is released. Next, an H2O molecule activated by His attacks the acyl-
enzyme intermediate which results in the release of the C-terminal part of the cleaved peptide bond.
FIGURE 4. Schematic representation of the specificity pocket numbering
convention in proteases. Conventionally, the nomenclature of Schechter and
Berger is used to address the specificity pockets. Residues and specificity
pockets located at the N-terminal side of the cleaved bond are referred to as
P1, P2, … and S1, S2, … respectively. Likewise, residues and specificity
pockets located at the C-terminal side of the cleaved bond are designated
P1’, P2’, … and S1’, S2’, … respectively. The cleaved peptide bond is
situated between the P1 and P1’ positions in the peptide.
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fragmentation, protein domain separation, and protein trunca-
tion. Because the focus of this review is the position of trypsin in
proteomics, an overview of a typical shotgun experiment follows
with emphasis on the steps where trypsin is involved.
The first step of a shotgun experiment involves isolation of
the proteome of interest from a cell, tissue, or organelle. The
protein mixture is denaturated and site-specifically cleaved into
peptides with the aid of a protease, a role typically carried out
with trypsin because of its favorable characteristics for mass
spectrometry. The resulting, highly complex peptide mixture is
separated with reversed-phase liquid chromatography (LC),
which relies on the solubility of the peptides in an organic
solvent compared to their affinity for a hydrophobic stationary
phase (Berg, Tymoczko, & Stryer, 2002). After elution from the
LC column, the peptides enter the mass spectrometer, where
they are analyzed with tandem mass spectrometry (MS/MS)
(Gevaert et al., 2007; Matallana-Surget, Leroy, &Wattiez, 2010;
Walther & Mann, 2010). Nowadays, the LC and MS steps are
coupled: the peptide mixture elutes directly off the column and
into the mass spectrometer. The high degree of automation
makes this experimental setup very suitable for high-throughput
analysis of protein mixtures (Washburn, Wolters, &
Yates, 2001). To identify the obtained fragmentation mass
spectra, specialized algorithms called database search engines
first generate theoretical spectra from in silico fragmentation
of peptides obtained after in silico digestion of the protein
sequence database of the sample (Frewen &MacCoss, 2007). To
achieve maximal efficiency, this step ideally builds upon full
knowledge of the specificity of the protease to allow optimal
prediction of cleaved peptides. Finally, the measured spectra,
which contain pairs of mass-to-charge (m/z) ratios and ion
intensities, are matched against theoretically derived spectra
to identify the parent peptide and infer the precursor protein
with the aid of search algorithms such as Mascot (Perkins
et al., 1999), OMSSA (Geer et al., 2004), and X!Tandem (Craig
& Beavis, 2004). The outcome of the algorithm is a hit list based
on scores that reflect the degree of resemblance between
the observed and theoretical spectra (Sadygov, Cociorva, &
Yates, 2004). To estimate the false discovery rate (FDR) of such
a peptide or protein hit list, a decoy database can be used. The
FDR is defined as the frequency at which spectra are matched
against an entry from the decoy database at a given score
threshold (Ka¨ll et al., 2008). Decoy databases can be obtained in
various ways, but the most popular methods consist of a simple
reversal of the original database or a shuffle of the original
database (Feng, Naiman, & Cooper, 2007).
A. Trypsin as a Tool in Proteomics
Over the years, trypsin was, together with ovalbumin and
hemoglobin, often among one of the first enzymes on which a
new technique was tested. Trypsin owes this pioneering position
to its ready availability. In the early years, protein purification
was based on fractional precipitation with ammonium sulfate to
produce a crystalline protein, and trypsin was one of the first
proteins to be purified on an industrial scale via this method
(Neurath, 1994).
In mass spectrometry-based proteomics, trypsin is by far
the most popular protease. Trypsin owes this position to its high
efficiency, cleavage-site specificity, and the fact that the tryptic
peptides are easily amenable to mass spectrometry-based
analysis. The relation between a theoretical tryptic digest and
the observed peptides via mass spectrometry is illustrated in
Figure 5 which represents the probability histograms of the
peptide-length distribution of a trypsin digest of the human
complement of UniProtKB/SwissProt (Jain et al., 2009; Uniprot
Consortium, 2011) and the peptide-length distribution found
from shotgun proteomics identifications from human samples,
as obtained from the PRIDE database (Martens et al., 2005a;
Vizcaı´no et al., 2009). The in silico trypsin digest of the human
proteome was performed with DBToolkit (Martens, Vande-
kerckhove, & Gevaert, 2005), which allowed for one missed
cleavage. It is clear that the overall trypsin digest falls within the
range of the mass spectrometer apart from very small and very
large peptides. Finally, the presence of a basic residue at the C-
terminus of the peptide leads to more-efficient positive ioniza-
tion, and in concert with the basic nature of the N-terminus of
the peptide, to overall favorable fragmentation characteristics.
Trypsin plays a central role in two distinct but essentially
parallel steps of a typical mass spectrometry-based proteomics
experiment. Trypsin is used to digest the protein mixture of
interest into a complex tryptic peptide mixture, but it is also
mimicked in silico to perform the digest of the protein sequence
database of the sample that is analyzed. As such, the in silico
workflow aims to replicate faithfully the in vitro workflow. This
in vitro workflow typically starts with solubilization and
denaturation of proteins in the mixture by adding detergents
such as sodium dodecyl sulfate (SDS) or sodium deoxycholate
(SDC) and chaotropic agents such as urea or guanidinium
hydrochloride. Typically, dithiotreitol (DTT) is added to reduce
disulfide bridges, followed by alkylation of the reduced Cys
with iodoacetic acid (IAA) or iodoacetamide (IAN). Finally,
trypsin is added at a 1:30–1:50 trypsin: substrate molar ratio,
sometimes complemented with 2 mM CaCl2. The resulting
mixture is incubated overnight at 37˚C with shaking, typically
FIGURE 5. Superposition of the probability histograms of the peptide
length distribution of a trypsin digest of the human complement of UniProt/
SwissProt and the peptide length distribution found from shotgun proteomics
identifications from human samples obtained from the PRIDE database. The
peptide length distribution of the trypsin digest is colored in blue, the peptide
length distribution from the peptides originating from the PRIDE database is
colored in red. For clarity, the histogram only contains information about
peptides up to a maximum length of 50 residues.
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for approximately 16 hr, to obtain full digestion of the protein
mixture (Klammer & MacCoss, 2006; Hervey, Strader, &
Hurst, 2007). It is worth noting however, that digest protocols
can vary substantially between labs.
The ideal denaturation and digestion protocol is one where
complete digestion of all proteins in the sample takes place,
because complete digestion provides the maximal possible
number of observable peptides. Usually however, the digestion
efficiency varies from protein to protein, and even from peptide
to peptide to result in variations in the tryptic peptides. This
variability in digestion efficiency affects the amount of peptide
that is available for detection, and has an adverse effect on the
reproducibility of analyses (Proc et al., 2010). To gain insight in
the origins of this variability, a study of the different digestion
protocols was performed by Proc et al. (2010) to determine the
conditions in which the highest possible percentage of the
proteins is digested in the most reproducible way. This study
showed that digestion conditions are protein-dependent; there is
no one common procedure that is optimal for all proteins.
Therefore, alteration of the denaturation condition towards
properties of the protein sample can improve digestion efficien-
cy (Proc et al., 2010). Some proteins such as myoglobin and
membrane proteins are difficult to digest. For these proteins,
addition of SDC improves denaturation, solubilization, and
subsequent trypsin digestion to result in improved identification
and sequence coverage (Lin et al., 2008). RapiGestTM, an acid-
labile surfactant, is another reagent that improves solubilization
and denaturation of proteins, while maintaining the activity of
trypsin without an influence of its degradation products on MS
analysis (Chen et al., 2007). The importance of the conservation
of trypsin activity is in contrast with the common use of urea,
which reduces trypsin activity and potential carbamylation of
Lys and/or Cys. The result of RapiGestTM thus resembles SDC,
to lead to an increase in protein identifications by improving
solubilization and denaturation of proteins without reduction of
protease activity (Klammer & MacCoss, 2006). The traditional
use of urea is to some extent attributable to the ease with which
it can be removed from the peptide mixture (Gordon &
Jencks, 1963; Greene & Pace, 1974). In combination with
trypsin, however, urea can only be used at concentrations below
2 M to maintain sufficient trypsin activity; a similar effect is
seen for guanidinium hydrochloride (Staes et al., 2004). When
higher concentrations (6–8 M) of urea are needed to obtain
sufficient protein denaturation, LysC should be the protease of
choice because it is more stable to chaotropes (Raijmakers
et al., 2010).
An ideal denaturation and digestion protocol should not
only lead to complete digestion of a protein sample, but should
also not interfere with LC-MS analysis. This latter motive
provides an incentive to switch from SDS to RapiGestTM
because SDS is difficult to remove from the final peptide mixture
(Wis´niewski et al., 2009) whereas RapiGestTM does not seem to
interfere with MS measurements (Chen et al., 2007) and can be
left in the sample.
Because of the variety of ways in which digestion can be
carried out, there is no single universal protocol available for
protein digestion prior to a mass spectrometry. This lack of a
universal protocol is not just because individual laboratories
favor different, typically in-house protocols, but also because
the best protocol for an experiment depends on the specifics of
the sample, the properties of the proteins that should be
analyzed, and the ultimate aim of the analysis. As a result, the
literature abounds with protocols for digestion that are tailored
to specific applications. However there is also an unmet need for
a “gold standard,” verified, simple yet efficient general purpose
digestion protocol. The community would do well to invest
some time and energy into development of such a protocol.
Beyond the influence from the denaturation and digestion
protocol the efficiency of trypsin is also influenced by the brand
of trypsin that is used. This was recently demonstrated by
Burkhart and co-workers who analyzed the performance of six
different trypsin preparations, retrieved from different vendors
and belonging to different price ranges. They revealed consider-
able differences in protease performance which do not fully
correlate with the price of trypsin (Burkhart et al., 2012). To
meet a “gold standard” in proteomics, Burkhart and co-workers
recommend some procedures as routine workflows for digestion
and trypsin control. They propose monolithic column-based
separations as a quality control for the digest. To evaluate the
specificity of cleavage, SCX-enriched semi-tryptic fractions in
conjunction with a three-step database search strategy are
advised. The degree of missed cleavages and their reproducibili-
ty should then be evaluated by selected reaction monitoring
(SRM) of selected peptide pairs (Burkhart et al., 2012).
B. The Evolution of Trypsin Into an Engineered
Enzyme
Trypsin can be bought commercially from several companies,
including Promega, Sigma-Aldrich, Roche, and Worthington
Biochemical. The latter was among the first to provide crystal-
line trypsinogen. The application of trypsin in a proteomics
experiment demands stringent specificity, and the autolysis of
trypsin, which results in a broadened specificity, including
chymotrypsin-like activity, therefore must be prevented as much
as possible (Weil & Timasheff, 1966). This goal is achieved
by modification of the native trypsin. The Lys residues are
reductively methylated to yield a product that is highly active,
stable, and most-importantly, resistant to autolysis (Rice,
Means, & Brown, 1977). This resistance originates from the
inability of trypsin to recognize and cleave methylated Lys
(Joys & Kim, 1979; Poncz & Dearborn, 1983). Despite these
alterations, autolysis of commercial trypsin can still occur;
trypsin fragments can be used as internal mass calibrants
(Harris, Janecki, & Reilly, 2002). This modified trypsin can
further be treated with TPCK (N-alpha-tosyl-L-phenylalanyl
chloromethyl ketone), an inhibitor for serine proteases with
specificity for chymotrypsin and chymotrypsin-like proteases,
to remove chymotryptic activity (Tobita & Folk, 1967; Rokhlin
et al., 2004). Trypsin is subsequently purified via affinity
chromatography and lyophilized to retrieve trypsin of high
specificity and robustness.
At the end of the digestion phase, the activity of this heavily
engineered trypsin must be stopped. This termination of activity
is of particular importance for experiments where only limited
proteolysis is required. This “shutdown” of trypsin can be
obtained with acidification of the mixture [placing it on ice, and
add formic acid (Smillie & Neurath, 1959) or trifluoroacetic
acid]. Acidification is, however, not sufficient when the digest is
used to label peptide C-termini with heavy oxygen (18O) for
quantitative analysis (a procedure carried out in H2
18O)
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(Desiderio & Kai, 1983), because residual tryptic activity will
cause clearly noticeable back-exchange of the heavy isotopes
with H2
16O once the digest is again transferred into unlabeled
water, as shown by Staes et al. (2004). To completely terminate
tryptic activity, Staes et al. reported the use of performic acid
oxidation; however this acid caused chemical back-exchange of
the heavy-labeled oxygen due to the very acidic pH. The final
recommendation by these authors was to covalently modify the
thiol groups of trypsin, and subject trypsin to 3 M guanidinium
hydrochloride. At this concentration of the potent chaotrope,
trypsin was sufficiently denatured to lose all activity, especially
because the covalent modification of the trypsin thiol groups
prevented (transient) reformation of the active structure of
trypsin.
C. Current Knowledge on the Characteristics of
Trypsin (Mis-)Cleavage
The reason behind the specificity for positively charged residues
was elucidated early on during the co-crystallization of trypsin
and an inhibitor, pancreatic trypsin inhibitor. Analysis of the
structure of this complex revealed the salt bridge between
the Lys from pancreatic trypsin inhibitor and the Asp 195 in the
bottom of the S1 pocket of trypsin (Ru¨hlmann et al., 1973).
Contrary to expectation, trypsin cleavage is not always repro-
ducible or predictable. Indeed, trypsin, like other proteases,
can skip a seemingly cleavable residue. This skip results in a
so-called miscleaved position. For trypsin, these miscleaved
positions have been extensively analyzed to result in the Keil
rules for miscleavage (summarized in Table 1; Keil, 1992).
Some of these rules are also implemented in various database
search engines to ensure more-accurate in silico cleavage of
peptides. The best-known rule is the occurrence of a missed
cleavage when Arg or Lys is followed by a Pro. This propensity
for miscleavage is mechanistically explained by the atypical
conformation imposed on the Arg or Lys by Pro (Olsen, Ong, &
Mann, 2004). Another frequently occurring missed cleavage is
found when two or more positively charged residues follow each
other. In this situation, trypsin cleaves after the most C-terminal
positively charged residue (Thiede et al., 2000). The last rule
relates to the presence of negatively charged residues in close
proximity to the Lys or Arg, a configuration that again promotes
miscleavage. When the Asp or Glu are immediately next to the
Arg or Lys, only one negatively charged residue is necessary to
obtain miscleavage. When the acidic residue is located at
position j  2 or j  3, at least one additional Asp or Glu must
be nearby (see Table 1). These missed cleavages are most likely
the result of salt bridges formed between the negatively charged
residue and the Arg or Lys. The negative residues in close
proximity to the Lys or Arg thus compete with the Asp at the
bottom of the S1 pocket to competitively inhibit its interaction
with the Arg or Lys (Thiede et al., 2000; Yen et al., 2006; Siepen
et al., 2007).
The rules described so far all depend on residues in close
proximity to the possible cleavage site; they all depend
exclusively on sequence information. Hamady and co-workers
introduced several structural parameters in their analysis of
missed cleavages (Hamady et al., 2005). They focused on
secondary structure, changes in secondary structure, and the
exposed surface area of the residues that surround the cleavage
site. They found that the average exposed surface area at the
incorrect cleavage sites is greater than that of the correct
cleavage sites; that result is at odds with the intuitive notion that
residues buried inside the protein should be less accessible and
therefore less readily cleaved. The authors propose that these
miscleaved positions might occur in “nests” of acidic residues.
This proposal is in agreement with the miscleavage rule that
states that negatively charged residues that surround Arg or Lys
result in miscleavage. When secondary structure is considered,
Hamady et al. found that cleavage sites within unstructured
regions are slightly more likely to be cleaved incorrectly,
whereas cleavage sites within alpha-helices were slightly more
likely to be cleaved correctly (Hamady et al., 2005).
Despite this established body of knowledge on the cleavage
specifics of trypsin, it remains very difficult to accurately predict
missed cleavage sites for a given protein. This difficulty
primarily impacts targeted proteomics studies, where precise
prediction of cleavage propensity can play a crucial role in the
delineation of potential proteotypic peptides.
IV. THE FUTURE OF TRYPSIN IN PROTEOMICS
A. The Need for Expansion of Common Knowledge
on Trypsin cleavage
Nowadays, mass spectrometry-based proteomics experiments
are not merely dedicated to the characterization of protein
mixtures. Indeed, they are more often performed to identify
or quantify specific proteins or peptides at high throughput yet
with high specificity. To propose optimal peptide targets, it is
important to correctly predict the outcome of tryptic cleavage of
the proteins of interest. The peptide to target must be cleaved
reliably on both its tryptic termini in order for it to be routinely
observable, and the presence of an unknown percentage of
miscleaved variants will interfere with quantification. The
currently known rules for missed cleavage cannot predict
TABLE 1. Summary of the Keil rules for miscleavage by trypsin
P4 P3 P2 P1 P1’ P2’ P3’
   [RK] [P]   
   [RK] [RK]   
  [DE] [RK]    
   [RK] [DE]   
   [RK]  [DE] [DE] 
[DE] [DE]  [RK]    
 [DE]  [RK]  [DE]  
The different patterns of miscleavage are represented as regular expressions. Letters within a set of square brackets are
considered to be only one symbol, equal to any one of the letters inside the brackets.
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upwards of 10% of the observed missed cleavages. They also
cannot stochastically predict cleavage or miscleavage (Thiede
et al., 2000); a prediction that would be of great value because
cleavage is rarely an all-or-nothing event; whereas some sites
are always cleaved and other sites are never cleaved, many other
sites are cleaved stochastically. The ability to predict stochastic
cleavage would improve database search algorithms, aid more-
reliable quantification, and provide the ability to select more
accurate targets for SRM experiments.
Typical shotgun proteomics would perhaps not benefit
dramatically from improved tryptic cleavage specificity because
the current lack of precision can be circumvented by simulta-
neously considering one or more missed cleavages for each
peptide in an in silico digest. Because all possibilities are
covered, and whereas the search engine might waste some
compute cycles, it will not lose information. The main impact
can be expected in quantitative studies and targeted SRM
analyses. The former will benefit because knowledge of stochas-
tic miscleavage can help predict where a certain proportion of
undetectable miscleaved variants of a peptide will cause an
underestimation of the peptide quantification. Ideally, the
reliability of the prediction would be such that a quantification
shortfall can be corrected for. In the case of targeted proteomics
with SRM, miscleavage prediction plays a crucial role. Indeed,
the position of miscleavage and—ideally—the rate of miscleav-
age must be accurately predicted to correctly predict and
quantify target peptides (Lange et al., 2008; Holman, Sims, &
Eyers, 2012; Reker &Malmstro¨m, 2012).
Another application that requires full knowledge of the
specificity of proteases is the use of accurate mass tags for
protein identification in peptide mass fingerprinting. The current
resolution of mass spectrometers allows such tags to be
measured with very high mass accuracy to enable their use for
high-throughput protein identification. The idea behind this
approach is based on the observation that a particular proteome,
if digested with a specific protease such as trypsin, will generate
a peptide mixture in which most peptides can be uniquely
classified based on their accurate mass and one or more
additional parameters such as chromatographic retention times
(Conrads et al., 2000; Smith et al., 2002; Pasa-Tolic´ et al., 2004).
Finally, a recent approach by the Yates group specifically
aims to leverage the concentration-dependence of the speed of
tryptic cleavage for any given protein, to reduce the footprint of
highly abundant proteins in complex mixtures (Fonslow
et al., 2013). The approach, called DeagDePr, relies on a partial
initial digest of a complex proteome, in which highly abundant
proteins are preferentially digested into peptides due to their
faster digest kinetics, and a subsequent molecular-weight-cutoff
filtration step is then used to remove these peptides. The
remaining mixture is thus enriched for less abundant proteins
that have escaped the initial digest. A downside of the method
however, is that it requires more starting material (the published
study used 10 times the normal protein mass) than a typical
proteomics experiment.
B. Contradictions Within the Common Knowledge
on Trypsin Cleavage
As stated above, the currently known rules to predict miscleav-
age cannot explain ca. 10% of observed miscleavages.
Moreover, all these rules use only the local sequence as the
information source. It is quite possible that the currently
unexplained miscleaved positions are due to residual structure
and local conformation. Whereas structural analysis of the
specific substrates of trypsin and chymotrypsin showed that, for
binding pockets S1, S2, S1’, and S2’, no structural constraints
are placed on the residues that bind to these pockets; the S3
pocket does seem to enforce some structural constraints. The
residue that binds this S3 pocket shows a sharp bend at its
backbone, and the residues on each side of this bend are in a left-
handed helical conformation that resembles the conformation of
collagen. This bending results in the formation of a hydrogen
bond between the main chain of trypsin and the main chain of
the bound substrate. This conformation is consistent with the
expectation that trypsin attacks the most-exposed parts of the
molecular surface, which are mainly found in loops. From this
analysis, it is clear that the specificity of the S3 pocket does not
reside in the identity of a particular residue but in the
presentation of hydrogen-bonding groups (Wright, 1977).
The general accepted rule of miscleavage is that trypsin
cleaves next to Arg and Lys unless they are followed by a Pro.
This rule was derived several decades ago and was based on a
small number of experimentally confirmed cleavages. A more
recent study re-examined this rule with the large data sets of
available spectra. To limit the number of false discoveries, only
doubly confirmed cleavages were retained in the data set. This
analysis revealed that the presence of cleavages between (Arg/
Lys) and Pro is not dramatically larger than the number of
cleavages between (Arg/Lys) and Trp, and (Arg/Lys) and Cys,
which are both generally accepted tryptic-cleavage sites. From
these observations, Rodriguez and co-workers suggest that
cleavage before Pro might also be a tryptic event but perhaps
with less propensity for cleavage than other sites (Rodriguez
et al., 2008) to highlight a shift from a deterministic non-
cleavage to a stochastic rule.
Another generally accepted rule of miscleavage that can be
questioned is the rule that trypsin does not cleave if the Arg or
Lys is closely surrounded by negatively charged residues. This
question is illustrated by a very salient example: trypsin can
activate itself by autocatalysis when it cleaves the N-terminal
peptide from trypsinogen. This autocatalysis involves cleavage
of a Lys-Ile bond that is preceded by Val-Asp-Asp-Asp-Asp, and
should have low cleavage propensity. Compared to the alterna-
tive preceding sequence of Val-Ala-Ala-Ala-Ala, the autocleav-
age indeed occurs at a lower rate that indicates that aspartyl
residues do have a negative effect. Addition of high Ca2þ
concentrations can reverse this effect. This reverse effect can be
explained by the observation that Ca2þ binds to the aspartyl
residues to shield their negative charges (Abita, Delaage, &
Lazdunski, 1969). This slow autocatalysis is most likely a
protection in case of an accidental activation. The stability of the
zymogen system depends on a limit of the concentration of
trypsin, which activates all pancreatic zymogens, to a minimum
during intracellular transport, concentration and storage in the
zymogen granule, and even for some time after extrusion into
the pancreatic juice. Even small amounts of trypsin are sufficient
to activate all available zymogens; in case of erroneous
activation, acute pancreatitis might ensue (Hirota, Ohmuraya, &
Baba, 2006; Sha, Ma, & Jha, 2009; Ji & Logsdon, 2011).
The Keil rule which states that miscleavage occurs when
two or more successive positively charged residues follow each
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other can also be questioned. Upon analysis of the human tryptic
peptides available in PRIDE, we have found that 57% of the
successive positively charged residues are correctly cleaved.
The above illustrates that, although implementation of these
rules in search algorithms might reduce search time by limiting
the search space, they can also result in wrongly identified
peptides due to a mismatch between the peptides in the sample
and the presumed peptides after in silico digest of proteins in the
database. Obviously, improper use of these rules can also lead to
a significant loss of identified peptides, whenever a cleaved
peptide such as one that originates from an (Arg/Lys)-Pro
cleavage, is not even considered by the search engine.
C. How to Overcome Shortcomings of Trypsin in
MS Applications
Cleavage of a proteome with a protease such as trypsin results in
many peptides of various lengths. For a mass spectrometry-
based experiment, only peptides composed of 7–35 residues
(corresponds roughly to a mass range of 600–4,000 Da) can
typically be detected reliably due to limitations in the resolving
power of the LC and MS instruments. Indeed, any one protease
will only reveal certain parts of the proteome through the subset
of detectable peptides that it generates. Other parts of the
proteome will be cleaved into peptides that are either too small
or too large to be detected, and leave this part of the proteome
inaccessible to MS-based analysis. The limitations of one
protease can be (partially) compensated for with another
protease with different specificity in parallel on the same
sample. Indeed, judicious use of different proteases in parallel
within one experiment will result in a better sequence coverage
and a higher number of identified proteins (Schlosser, Vanselow,
& Kramer, 2005; Fischer & Poetsch, 2006; Swaney, Wenger, &
Coon, 2010). Another drawback of the use of only one protease
is that digestion conditions are protein-dependent. Hence, for a
certain protein mixture, the protease of choice might not obtain
its maximal proteolytic efficiency. Gatter and co-workers
demonstrated that, to keep the number of missed cleavage in a
trypsin digest low, an additional cleavage step with LysC can be
very helpful (Glatter et al., 2012).
A particularly interesting analysis can also be carried out
with regards to the resolution limitations of trypsin in a global
human proteome analysis. With efforts to establish a human
proteome project now underway (Hancock et al., 2011; Paik
et al., 2012a,b), such an in silico analysis is of particular
relevance, especially because there has been some debate
about the relative merits and caveats of a gene-centric versus a
protein (isoform) centric concept (Rabilloud, Hochstrasser, &
Simpson, 2010). It is interesting to see from Figure 6 that the
usefulness of parallel digests is relatively limited for a gene-
centric proteome project, because trypsin alone yields unique,
identifiable peptides that cover more than 98% of all human
genes (top chart in Figure 6, dark circles). Use of two to six
proteases in parallel does increase the coverage, but the gains
are very small compared to the increased cost in complexity
(second from bottom chart in Figure 6, open squares; complexity
is counted in number of unique peptide sequences obtained, and
is normalized to one for trypsin). The picture changes quite a bit
when splice isoforms are taken into account because the
maximal theoretical coverage by peptides unique to a single
splice isoform drops to a little under 82% for trypsin (Fig. 6, top
chart, open circles). As a result, parallel digests do yield
important benefits here, with an optimal combination found at
combination index 27 (overall X-axis) for the protease trio of
Arg-C, Lys-C, and V8E at slightly more than 88% coverage.
This optimal combination also clearly stands out in the cost-
benefit chart (bottom chart in Figure 6, black circles; higher is
better), where the cost in complexity is compared to the gain in
coverage. Note that this combination essentially replaces a
trypsin digest with parallel Arg-C and Lys-C digests to obtain
longer and more uniquely mapping peptides and better cover-
age. If all six enzymes considered here were to be used in
parallel (combination index 63 at the right-hand side of the
chart), coverage of isoforms would be <92%, to yield relatively
little gain compared to the large increase in complexity, to result
in one of the lowest cost-benefit scores for any combination of
proteases. This chart makes it clear that unique identification of
peptides for each known protein isoform in the human proteome
is essentially impossible in theory, and that simple analysis of as
many proteases in parallel as possible is clearly not the optimal
strategy. It is wise to carefully plan experiments aimed to
identification of a large amounts of protein isoforms uniquely,
because achievement of this goal is already rendered surprising-
ly difficult by the digest alone. As such, a human proteome
project is probably best planned as a gene-centric project at first,
fostering research into improved methods and parallel digests to
increase protein isoform coverage for a future expansion of the
project.
D. The Role of Trypsin in the Future
In the trypsin applications described so far, the hydrolysis
always takes place under denaturing conditions to expose and
cleave as many peptide bonds as possible. Proteases such as
trypsin can also be used with substrates in their native state, and
it is the structure and not the sequence that will determine the
sites of initial hydrolysis. The limited cleavage, also called
limited proteolysis, is already used as a tool to investigate
protein structure. The rationale of limited proteolysis is that
peptide bonds buried in the core of the protein or located in
secondary structure elements will be less accessible to the
protease and are not cleaved as quickly as more accessible,
surface-exposed residues. As such, limited digests of native
proteins preferentially yields peptides located on the surface of
the protein or in exposed loop regions (Fontana et al., 1997;
Hubbard, 1998; Tsai et al., 2002).
Another future role for trypsin can be found in highly
sensitive approaches to quantitative protein analysis that are
based on a combination of proteolytic digest, antibody-based
enrichment, and mass spectrometry. Protein cleavage followed
by specific enrichment of proteotypic peptides with the aid of
anti-peptide antibodies and subsequent identification of the
captured peptides provides mass spectrometry with a central
role in the field of protein biomarkers because even very small
quantities of proteins can be measured with high sensitivity and
absolute specificity (Meyer & Sthler, 2007; Alvarez-Llamas
et al., 2008; Anderson et al., 2009; Poschmann et al., 2009).
Finally, another specialized application of trypsin with an
interesting application is so-called cell shaving, where trypsin is
added to cultured cells to cleave off the extracellular parts of
(trans-) membrane proteins (Tjalsma et al., 2008; Braconi
Mass Spectrometry Reviews DOI 10.1002/mas 461
TRYPSIN IN PROTEOMICS &
et al., 2011; Viala´s et al., 2012). This approach also allows the
study of cellular interactions, as for instance found between a
pathogen and a host cell (Dreisbach et al., 2011).
E. The Use of Trypsin Beyond Proteomics
Apart from being the main protease in proteomics, trypsin is
also used in other biochemical and biomedical methods. One of
these applications is its use in the isolation and culture of cells.
Here, trypsin is used to cleave proteins that bind cells to a dish
wall (Hentzer & Kobayasi, 1975; Kirkpatrick, Melzner, &
Go¨ller, 1985). A specific example is isolation and culture of
mesenchymal stem cells from bone marrow, where trypsin is
used to separate the different cell types (Soleimani &
Nadri, 2009). Trypsin is also involved in the isolation of retinal
endothelial cells, where it is used to remove pericyte contamina-
tion (Banumathi et al., 2009).
Apart from its use in biochemical methods, trypsin has also
found its way into medicine as a means to remove blood clots
(Grabe & Forsberg, 1986).
Trypsin also plays an important industrial role in the
production of hydrolyzed cow milk formula for newborns (von
Berg et al., 2003). This hydrolyzed cow milk is the preferred
formula for newborns with cow-milk allergy; an allergy against
bovine beta-lactoglobulin (Kattan, Cocco, & Ja¨rvinen, 2011).
Hydrolysis of this protein with trypsin removes the epitopes of
beta-lactoglobulin and prevents an allergic reaction (Ehn
et al., 2005; Duan et al., 2012).
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FIGURE 6. Cost-benefit analysis of proteases and protease combinations when analyzing the human proteome.
The charts arranged from top to bottom are: (i) the proteome coverage for genes (dark circles), for genes with
splice isoforms (light gray circles), and for all known proteins including splice isoforms (open circles); (ii) the
signature peptide frequency, that is, the number of obtained peptides that are unique to a particular splice isoform;
(iii) the complexity increase as measured by the total number of unique peptide sequences obtained; the number
for trypsin is normalized to one; and (iv) the cost-benefit score (reflecting the normalized ratio of the coverage
gain compared to trypsin over the complexity increase) for all 63 combinations of the six proteases considered.
The protease combinations are numbered along the X-axis, and their composition can be read on the legend on
the right.
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